Bank of America
NEPH icon

Bank of America’s Nephros NEPH Stock Holding History

Bank of America’s Portfolio NEPH Stock Details NEPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-73
Closed -$356 – 6485
2025
Q4 		$356 Sell
73
-19
-21% -$97 ﹤0.01% 6614
2025
Q3 		$435 Sell
92
-30
-25% -$118 ﹤0.01% 7615
2025
Q2 		$499 Buy
122
+43
+54% +$115 ﹤0.01% 7669
2025
Q1 		$136 Buy
79
+3
+4% +$5 ﹤0.01% 7771
2024
Q4 		$112 Sell
76
-20
-21% -$30 ﹤0.01% 7715
2024
Q3 		$164 Buy
96
+20
+26% +$40 ﹤0.01% 7611
2024
Q2 		$160 Buy
+76
New +$164 ﹤0.01% 7608
2024
Q1 		– Sell
-8
Closed -$28 – 8041
2023
Q4 		$28 Buy
+8
New +$17 ﹤0.01% 7598
2023
Q1 		– Sell
-14
Closed -$16 – 8118
2022
Q4 		$16 Buy
+14
New +$15 ﹤0.01% 8019
2022
Q1 		– Sell
-14
Closed – – 8582
2021
Q4 		$0 Sell
14
-155
-92% -$1.13K ﹤0.01% 8493
2021
Q3 		$1K Buy
169
+109
+182% +$945 ﹤0.01% 7991
2021
Q2 		$1K Buy
60
+35
+140% +$292 ﹤0.01% 7635
2021
Q1 		$0 Buy
+25
New +$197 ﹤0.01% 7653

Other funds holding NEPH

WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CC
Cornerstone Capital Palo Alto, California $1.12B AUM 28.84% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
MFIM
Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Bank of America's NEPH Position: Q1 2026 in Review

Bank of America sold out of Nephros (NEPH) in Q1 2026, closing a stake of 73 shares — an estimated $356 sold.

Bank of America first reported a position in NEPH in Q1 2021 and held it in 13 quarters. The position peaked at $1K in Q3 2021. 27 funds tracked by Wall St. Rank hold NEPH as of Q1 2026.

  • Bank of America reported no remaining Nephros position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 73 Nephros shares in Q1 2026, an estimated $356.
  • Bank of America first reported a position in Nephros in Q1 2021 and held it in 13 quarters.
  • Bank of America's Nephros position peaked at $1K in Q3 2021.
  • 27 funds tracked by Wall St. Rank held Nephros as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.